Shah Investor's Home Limited IPO
SHAHINVEST · Mainboard · 28–30 Sep 2026 · archived record
Half market demand (GMP, subscription, institutional bids), half offer-document data (valuation, profit trend, fresh issue vs OFS, debt, promoters, sector). Missing inputs are left out, not guessed. Not an apply/avoid recommendation.
No archived readings yet. Marketframe stores a reading every 15 minutes while an issue is live.
No archived readings yet. Marketframe stores a reading every 15 minutes while an issue is live.
All of this IPO is a fresh issue: every rupee raised goes to the company.
- ₹60 Cr: working capital
- Up to 25%: general corporate purposes
- 100% fresh issue (about ₹90 Cr at ₹167): no promoter is selling
Qualified institutional buyers are mutual funds, banks, insurers and foreign funds, and they read the full prospectus. They usually bid on the last day, so a low QIB number early in the window is normal. A low one at the close is not.
Promoter holding: 84.3% before the issue; about 63% after (our estimate at ₹167, as the RHP leaves it blank)
- Revenue: ₹77.8 Cr (FY24) → ₹94.3 Cr (FY25) → ₹71.5 Cr (FY26)
- Profit: ₹17.9 Cr → ₹23.4 Cr → ₹13.2 Cr
- FY26 revenue fell 24% and profit fell 44%
- RoNW fell from 13.9% (FY25) to 7.4% (FY26)
- About 19.9× FY26 earnings at ₹167 (EPS ₹8.38)
- The RHP's listed broking peers average 18.4× (range 11.7×–27.1×)
- About 1.5× book value (NAV ₹114.07)
- Priced at a modest premium to book value
- Mostly family-owned; promoters are not selling any shares
- Earnings shrinking: FY26 profit down 44%, yet priced near the peer average
- Negative operating cash flow in FY26
- Depends on a network of authorised persons (sub-brokers)
- Broking income swings with market volumes and SEBI rules
- Stock broking and distribution business
- Source: Shah Investor's Home RHP filed with NSE, September 2026
In 2 of the last 5 years, the typical Financial Services stock did better than the typical listed stock.
| Year | Typical stock | Clean average | Stocks up | Whole market | Abnormal moves set aside |
|---|---|---|---|---|---|
| 2021 | +22.6% | +28.1% | 74% of 76 | +45.5% | SHAREINDIA +482.7%, IEX +232.8% |
| 2022 | +14.1% | +21.5% | 63% of 86 | +3.0% | None |
| 2023 | +38.2% | +42.0% | 96% of 92 | +43.5% | BSE +307.6%, ANANDRATHI +269.7%, RECLTD +254.4% |
| 2024 | +11.0% | +20.0% | 64% of 98 | +23.1% | KFINTECH +218.5%, MOTILALOFS +207.5% |
| 2025 | +13.7% | +16.8% | 60% of 107 | -4.2% | None |
| 2026 YTD | -3.6% | +0.3% | 45% of 115 | -2.8% | PAISALO +112.1% |
Calendar-year returns of the Financial Services companies in the Nifty Total Market index, adjusted for splits and bonuses. The typical stock is the median, so one stock's spike or crash cannot pass for the whole sector. Moves more than three interquartile ranges from the middle are named and left out of the clean average. Only companies listed today are counted, so ones that collapsed and delisted are missing and past returns look better than they were. Past sector returns say nothing certain about this IPO.
Use NSE's official IPO bid and allotment verification page.
nseindia.comWhat is the GMP of Shah Investor's Home Limited today?
The latest unofficial grey market premium for Shah Investor's Home Limited is — (7.49% of the upper price band), sourced from InvestorGain. GMP is unofficial and unregulated.
What is the price band of Shah Investor's Home Limited?
The price band is ₹159–₹167 per share, as filed with NSE.
When does Shah Investor's Home Limited open and close?
The issue window is 28–30 Sep 2026. The current status is closed.
How much is Shah Investor's Home Limited subscribed?
Live subscription figures are published by NSE once bidding opens.
Is Shah Investor's Home Limited a good IPO to apply for?
Marketframe does not publish apply or avoid calls. The Marketframe score combines market demand (GMP, subscription, institutional bids) with facts from the offer document (valuation against listed peers, profit trend, fresh issue vs OFS, debt, promoter holding and sector record). It is an automated summary of data, not a recommendation or investment advice. Read the RHP and consult a SEBI-registered adviser.
↑Issue schedule verified from NSE
!GMP is unofficial and not verified by NSE
!Read the RHP risk factors before applying
Schedule, price band and live subscription data are sourced from NSE India. *GMP is sourced from InvestorGain, is unofficial and unregulated. The Marketframe score summarises market demand and offer-document data; it does not predict listing gains or returns. Marketframe does not provide investment advice. Verify every decision using SEBI, NSE, BSE and the relevant offer document.